Maravai Lifesciences Holdings Inc (OQ:MRVI)

Apr 18, 2024 07:36 am ET
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the grand opening of its new
Apr 10, 2024 04:05 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2024 financial and operating results after the market closes on...
Mar 12, 2024 04:15 pm ET
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of March. On March 19,...
Feb 23, 2024 08:31 am ET
Thinking about buying stock in Maravai Lifesciences, Abercrombie & Fitch, elf Beauty, IONQ, or Vanda Pharmaceuticals?
NEW YORK, Feb. 23, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRVI, ANF, ELF, IONQ, and VNDA.
Feb 22, 2024 04:05 pm ET
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and full year ended December 31,...
Feb 21, 2024 08:00 am ET
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted patents by the China National Intellectual Property Administration (CNIPA) and the Canadian Intellectual Property Office (CIPO). Patent numbers ZL 2023 1 0
Feb 13, 2024 08:30 am ET
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences® (Nasdaq: MRVI), announced today a strategic partnership for the quantification of Host Cell Proteins (“HCP”) from the...
Jan 29, 2024 08:00 am ET
Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2023 financial and operating results after the...
Nov 09, 2023 08:15 am ET
Maravai LifeSciences Announces November 2023 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of November. On November...
Nov 07, 2023 04:05 pm ET
Maravai LifeSciences Reports Third Quarter 2023 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2023, together...
Nov 02, 2023 06:47 am ET
TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’
TriLink BioTechnologies® (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its Analytical Sciences Center of Excellence (ASCE) hub. Expanding its comprehensive suite of analytical testing capabilities, this new center of excellence will minimize the de
Oct 17, 2023 08:15 am ET
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2023 financial and operating results after the market closes on...
Sep 29, 2023 08:15 am ET
Maravai LifeSciences Hosts 2023 Investor R&D Day
Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, hosted its 2023 Investor R&D Day featuring presentations by Trey Martin,...
Sep 19, 2023 09:31 am ET
Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Chief Innovation Officer Kate Broderick, PhD, has been named to the 2023 PharmaVoice 100...
Sep 05, 2023 04:15 pm ET
Maravai LifeSciences to Host 2023 Investor R&D Day
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it will host its 2023 Investor R&D Day on Thursday, September 28, starting...
Aug 23, 2023 08:15 am ET
Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit
Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading product and services provider for the detection and characterization of process-related impurities in biopharmaceuticals, received a 2023 R&D 100 Award from R&D...
Aug 09, 2023 04:15 pm ET
Maravai LifeSciences Announces August 2023 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of August. On August 16,...
Aug 07, 2023 04:05 pm ET
Maravai LifeSciences Reports Second Quarter 2023 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2023, together with...
Jul 27, 2023 04:05 pm ET
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that William “Trey” Martin, III has assumed the role of Chief...
Jul 24, 2023 04:05 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2023 financial and operating results after the market...
Jul 20, 2023 04:05 pm ET
Maravai LifeSciences Announces Appointment of New Director to the Board
Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Robert (“Chip”) Hance has stepped down from the Company’s...
Jun 06, 2023 08:00 am ET
Congressman Scott Peters Tours Maravai’s RNA manufacturing facility
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, recently hosted Congressman Scott Peters for a tour of the RNA manufacturing facility at Wateridge Circle in...
May 24, 2023 08:10 am ET
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion
TriLink has reliably delivered GMP services to its customers since the debut of its first cGMP manufacturing facility in 2015. Built to meet the need of a rapidly growing market, the new cGMP facility is expected to contribute to the development of vital mRNA therapeutics. The building has been designed for the cGMP manufacture of mRNA-based in vivo gene editing, gene-edited cell therapies, protein replacement therapies, cancer vaccines, and infectious disease vaccines.
May 09, 2023 08:00 am ET
TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its newest cap analog, CleanCap® M6 . The latest CleanCap analog is expected to help developers...
May 08, 2023 04:05 pm ET
Maravai LifeSciences Reports First Quarter 2023 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2023, together with...
Apr 17, 2023 04:15 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2023 financial and operating results after the market closes on...
Mar 28, 2023 05:00 pm ET
Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the release of its second Environmental, Social and Governance (ESG)...
Mar 08, 2023 08:00 am ET
Maravai LifeSciences Announces March 2023 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of March. On March 15,...
Feb 22, 2023 04:05 pm ET
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and full year ended December 31,...
Feb 01, 2023 08:00 am ET
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2022 financial and operating results after the...
Dec 01, 2022 04:01 pm ET
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced plans for William “Trey” Martin, III to serve as President of Maravai’s Biologics Safety Testing...
Nov 16, 2022 05:05 pm ET
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced it ranked 270 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing...
Nov 07, 2022 04:10 pm ET
New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and services provider for the detection and characterization of process-related impurities in biopharmaceuticals, announced today the launch of the MockV®...
Nov 03, 2022 04:05 pm ET
Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the months of November and December....
Nov 02, 2022 04:05 pm ET
Maravai LifeSciences Reports Third Quarter 2022 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2022, together...
Oct 19, 2022 08:10 am ET
Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation
Executive Chairman and former CEO of Maravai LifeSciences, Inc. (NASDAQ: MRVI) Carl Hull, has been reinstated as CEO of the company on an interim basis. Three subsidiaries of Danaher Corporation, two of which previously employed recently-appointed...
Oct 18, 2022 04:15 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2022 financial and operating results after the market closes on...
Oct 03, 2022 04:05 pm ET
Maravai LifeSciences Announces CEO Leadership Transition
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that its Board of Directors has appointed William “Trey” Martin, III as its chief executive...
Sep 13, 2022 08:00 am ET
TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI) and global provider of life science reagents and services, has expanded its GMP-grade product offering to include N1-Methyl-Pseudouridine-5’-Triphosphate...
Aug 15, 2022 04:05 pm ET
Maravai LifeSciences Announces September 2022 Investor Conference Schedule
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of September....
Aug 04, 2022 04:51 pm ET
CORRECTION: Maravai Lifesciences Reports Second Quarter 2022 Financial Results
In a release issued under the same headline earlier today, August 4th, by Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), please note that a variety of changes have been made throughout the release. These includes the wording of the...
Aug 04, 2022 04:03 pm ET
Maravai Lifesciences Reports Second Quarter 2022 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2022, together with...
Jul 19, 2022 08:00 am ET
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 4, 2022
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2022 financial and operating results after the market closes on...
Jul 06, 2022 04:05 pm ET
TriLink BioTechnologies, part of Maravai LifeSciences, Expands R&D Leadership Team
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI) and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, today announced that Kate Broderick, Ph.D., has...
Jun 27, 2022 08:00 am ET
Maravai LifeSciences Strengthens Executive Leadership Team to Support Long-Term Growth
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that Peter Leddy, Ph.D. (“Pete”) has joined the Company as Executive Vice President and Chief...
May 24, 2022 08:00 am ET
TriLink BioTechnologies, Part of Maravai LifeSciences, Announces Cooperative Agreement With Department of Defense
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI), and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, today announced a Cooperative Agreement with the...
May 11, 2022 04:05 pm ET
Maravai LifeSciences Announces May and June 2022 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the months of May and June. On May...
May 05, 2022 04:05 pm ET
Maravai LifeSciences Reports First Quarter 2022 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2022, together with...
Apr 21, 2022 05:01 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2022 financial and operating results after the market closes on...
Apr 12, 2022 07:00 am ET
BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY
MINNEAPOLIS, April 12, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cygnus Technologies, part of Maravai LifeSciences (NASDAQ: MRVI), announced today the launch of the Simple Plex™ HEK 293 HCP 3G assay for automated process impurity testing on the Ella™ immunoassay platform.
Mar 09, 2022 04:30 pm ET
Maravai LifeSciences Announces March 2022 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of March. On March 15,...
Feb 23, 2022 04:05 pm ET
Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and the full year ended...
Jan 28, 2022 08:00 am ET
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has acquired MyChem, LLC for $240 million in cash at closing with the potential for...
Jan 25, 2022 05:05 pm ET
Maravai LifeSciences Announces Upcoming Investor Events
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, will host a live video webcast of its Investor R&D Day on Friday, January 28, 2022. The event will feature...
Jan 20, 2022 04:05 pm ET
Maravai LifeSciences Announces Debt Repricing
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that it had successfully completed the repricing of its existing credit...
Jan 05, 2022 08:00 am ET
Maravai LifeSciences Announces Registration and Webcast Information for Upcoming R&D Day, to be Held on January 28, 2022
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced details for its first ever Investor R&D Day. The event will be held...
Dec 20, 2021 08:32 am ET
Dr. Jessica Hopfield Appointed to Berkeley Lights Board of Directors
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the appointment of Jessica Hopfield, Ph.D. to the Berkeley Lights’ Board of Directors as an independent director, effective December 15, 2021. "Dr. Hopfield is...
Dec 14, 2021 08:30 am ET
Maravai LifeSciences Added to the Nasdaq Biotechnology Index
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company has been added to the Nasdaq Biotechnology Index (Nasdaq:...
Dec 09, 2021 04:00 pm ET
Maravai LifeSciences Announces Establishment of New Charitable Foundation
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced it is establishing a new charitable foundation to promote causes tied to...
Dec 09, 2021 07:41 am ET
Direxion Launches mRNA ETF (MSGR)
NEW YORK, Dec. 9, 2021 /PRNewswire/ -- Direxion announced today the launch of the Direxion mRNA ETF (Ticker: MSGR). MSGR invests in companies believed to be at the forefront of the development and application of messenger RNA technology.
Nov 10, 2021 04:05 pm ET
Maravai LifeSciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance For 2022
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2021, together...
Nov 08, 2021 12:00 pm ET
New England Biolabs® releases next generation HiScribe™ in vitro transcription kit, incorporating TriLink® Biotechnologies' CleanCap® technology for mRNA synthesis
IPSWICH, Mass., Nov. 8, 2021 /PRNewswire/ -- New England Biolabs (NEB®) announced today that they have released a kit for the generation of in vitro transcribed synthetic mRNA capped using the TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), CleanCap Reagent AG.
Nov 02, 2021 08:30 am ET
Maravai LifeSciences Announces November 2021 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of November. On...
Oct 13, 2021 04:30 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2021 financial and operating results after the market closes on...
Oct 07, 2021 05:30 am ET
Maravai LifeSciences Expands its Intellectual Property Portfolio with European Patent
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that the European Patent Office has issued a new patent, No. 3352584, to the company’s TriLink...
Oct 04, 2021 08:30 am ET
TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea
TriLink BioTechnologies (“TriLink”), a Maravai LifeSciences company (Nasdaq: MRVI) and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, announced today that it expects to supply its proprietary...
Sep 10, 2021 06:30 am ET
Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the pricing of a public offering of 20,000,000 shares of Maravai’s Class A...
Sep 07, 2021 04:10 pm ET
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the commencement of a public offering of its Class A common stock by...
Sep 07, 2021 07:00 am ET
Maravai LifeSciences Announces September 2021 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of September. On...
Aug 11, 2021 08:30 am ET
Thinking about buying stock in CohBar, Mogo, BioCryst Pharmaceuticals, Hoth Therapeutics, or Maravai Lifesciences?
NEW YORK, Aug. 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CWBR, MOGO, BCRX, HOTH, and MRVI.
Aug 10, 2021 04:05 pm ET
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2021, together with...
Aug 02, 2021 06:00 pm ET
TriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine Development into APAC Region with the Chula Vaccine Research Center (Chula VRC), Bangkok
TriLink BioTechnologies (“TriLink”), a Maravai LifeSciences company (Nasdaq: MRVI) and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, has enabled Chula Vaccine Research Center, at the Faculty of...
Jul 21, 2021 07:07 am ET
Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap® mRNA Capping Technology
Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), for its industry-leading...
Jul 20, 2021 04:15 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, August 10, 2021
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2021 financial and operating results after the market closes on...
May 26, 2021 04:10 pm ET
Maravai LifeSciences Announces June 2021 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of June. On June...
May 10, 2021 04:05 pm ET
Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance
Maravai LifeSciences Holdings, Inc. (Maravai)(NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2021. Highlights...
May 05, 2021 04:10 pm ET
Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of May. On May 12,...
Apr 20, 2021 08:45 am ET
Biotech Veterans Troy Cox, Susannah Gray and Karen McGinnis Join Biosplice Therapeutics Board of Directors
Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, announced today the addition of three independent directors to its board. New...
Apr 13, 2021 04:15 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 10, 2021
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2021 financial and operating results after the market closes on...
Apr 12, 2021 04:30 pm ET
Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the closing of a public offering of 20,700,000 shares of Maravai’s Class A...
Apr 07, 2021 08:20 pm ET
Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the pricing of an upsized public offering of 18,000,000 shares of Maravai’s...
Apr 05, 2021 05:30 pm ET
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the commencement of a public offering of its Class A common stock by...
Apr 05, 2021 04:05 pm ET
Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range
Maravai LifeSciences Holdings, Inc. (Maravai or the Company) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today provided preliminary unaudited revenue and Income from Operations...
Mar 15, 2021 08:05 am ET
Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services
Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, has expanded its contract development and manufacturing organization (CDMO) capabilities at TriLink BioTechnologies...
Mar 02, 2021 04:05 pm ET
Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and the full year ended December...
Mar 01, 2021 07:05 am ET
Maravai LifeSciences Announces March 2021 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in two upcoming virtual investor conferences. On March 3, 2021, Carl Hull, Chief...
Feb 10, 2021 07:05 am ET
Maravai LifeSciences Expands Its Intellectual Property Portfolio
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that the United States Patent and Trademark Office has issued a new patent, United States...
Jan 28, 2021 04:15 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2020 financial and operating results after the...
Nov 24, 2020 04:15 pm ET
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the closing of its initial public offering of 69,000,000 shares of Class A common...
Nov 19, 2020 07:50 pm ET
Maravai LifeSciences Announces Pricing of an Upsized Initial Public Offering
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the pricing of its upsized initial public offering of 60,000,000 shares of...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.